**Who this is for** This role is for a strategic leader with extensive experience in diagnostics and/or pharmaceuticals, focused on building and managing partne
Work type: remote
Location: Redwood City, California, United States
Salary: $212,000 – $233,000/yr
Type: Full-time
**Who this is for** This role is for a strategic leader with extensive experience in diagnostics and/or pharmaceuticals, focused on building and managing partnerships. If you have a deep understanding of oncology, pathology, and precision medicine, and can drive biomarker adoption, this is a great opportunity. **Key highlights** You will be responsible for shaping and managing strategic partnerships with labs and pathologists to ensure the adoption of RAS biomarker testing. This critical role bridges regional challenges with cohesive biomarker protocols and commercial strategy. **You might be a good fit if you...** - Have a minimum of 7 years in strategic account management within diagnostics/pharmaceuticals, with a strong oncology/pathology/precision medicine background. - Possess a Bachelor's degree and a deep understanding of anatomic pathology, molecular diagnostics, and biotech launch environments. - Demonstrate strategic vision, cross-functional leadership, and proven ability to influence external stakeholders. - Can translate diagnostic insights into effective field and brand activation strategies.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Biomarker Strategic Engagement Lead will report to the Director of Biomarker Strategy and Execution, this role is responsible for shaping and managing strategic partnerships with local and regional labs and pathologists in academic institutions, community pathology groups, integrated delivery networks (IDNs), and broad pathology stakeholders to ensure actionable adoption of RAS biomarker testing for the purpose of standard of care testing and appropriate patient identification.
This is a critical role within the biomarker team for Revolution Medicine’s portfolio of investigational RAS(ON) inhibitors, targeting RAS-addicted cancers.
This position will be remotely based.
Responsibilities include:
Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, incentive, field kit benefits, or any other form of compensation and field kit benefits that are allocable to a particular employee remains in the Company's sole and absolute discretion unless and until paid and may be modified at the Company’s sole and absolute discretion, consistent with applicable law.